While major tech corporations capture the bulk of investor enthusiasm during the artificial intelligence boom, companies operating outside traditional technology sectors are also positioning themselves to capitalize on the trend. Businesses across retail and healthcare are integrating AI into their core operations, presenting compelling long-term opportunities for investors looking beyond the usual semiconductor and software giants.
Two distinct businesses illustrate how the artificial intelligence revolution is expanding into unexpected markets: e-commerce platform Shopify and medical device maker Dexcom.
Shopify: Driving E-Commerce Growth With Artificial Intelligence
When artificial intelligence began transforming the tech landscape, some skeptics assumed the technology might render certain e-commerce tools obsolete. Instead, Shopify has embraced AI to enhance its platform performance and deliver robust financial results.
During the second quarter, Shopify reported revenue of $3.6 billion, marking a 34% increase year over year that surpassed analyst expectations. Net income, excluding equity investments, grew 30%. The company credited a significant portion of its strong performance to its suite of AI-driven capabilities.
Shopify has rolled out various artificial intelligence tools designed to:
- Drive higher visitor traffic to merchant storefronts
- Improve overall product discovery for consumers
- Boost conversion rates and merchant productivity
Despite these gains, agent-driven commerce remains in its early innings. Backed by network effects and high switching costs, the company is well-positioned to turn AI integration into long-term earnings growth.
Dexcom: Upgrading Medical Devices With Intelligent Insights
Dexcom is a leader in continuous glucose monitoring (CGM) devices, which allow diabetes patients to track their blood glucose levels effectively. The adoption of CGM technology has fueled consistent financial results for the company, and its prospects in the large CGM market look bright independently of AI.
To further strengthen its offerings, Dexcom continues to innovate and launch increasingly more sophisticated CGM products equipped with increasingly better AI tools. These enhancements help the company attract more patients, illustrating how Dexcom can benefit from artificial intelligence over the long run.
By combining steady demand in the large CGM market with product-enhancing artificial intelligence features, Dexcom has carved out a unique path to participate in the broader tech revolution while delivering competitive returns over time.
